Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| JFrog LtdFROG · Entity 1682 | Director | July 16, 2026 | July 20, 2026 |
| Teads Holding Co.OB · Entity 7241 | Director · Former 10% Owner | July 27, 2021 | July 29, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
JFrog Ltd
Report date July 16, 2026 · Filed July 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 83,349 |
Ending reported balance
After 2026-07-16 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-07-16 · Sale · Disposed 8,001 · Balance 100,348 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 5, 2025. F2: This transaction was executed in multiple trades at prices ranging from $86.13 to $87.12. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Row 2 · 2026-07-16 · Sale · Disposed 11,923 · Balance 88,425 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 5, 2025. F3: This transaction was executed in multiple trades at prices ranging from $87.13 to $88.12. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Row 3 · 2026-07-16 · Sale · Disposed 4,576 · Balance 83,849 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 5, 2025. F4: This transaction was executed in multiple trades at prices ranging from $88.13 to $89.04. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Row 4 · 2026-07-16 · Sale · Disposed 500 · Balance 83,349 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 5, 2025. F5: This transaction was executed in multiple trades at prices ranging from $89.16 to $90.11. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 5, 2025.
F2: This transaction was executed in multiple trades at prices ranging from $86.13 to $87.12. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3: This transaction was executed in multiple trades at prices ranging from $87.13 to $88.12. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4: This transaction was executed in multiple trades at prices ranging from $88.13 to $89.04. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5: This transaction was executed in multiple trades at prices ranging from $89.16 to $90.11. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Teads Holding Co.
Report date July 27, 2021 · Filed July 29, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 4,921,763 |
Reported balance
After 2021-07-27 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2021-07-27 · Conversion · Acquired 4,383,637 · Balance 4,921,763 F3: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F1: The shares are held directly by Gemini Israel IV L.P. ("Gemini LP"), Gemini Israel IV (Annex Fund) L.P. ("Gemini LP Annex"), Gemini Partners Investors IV L.P. ("Gemini Partners") and Gemini Partners Investors IV (Annex Fund) L.P. ("Gemini Partners Annex," and together with Gemini LP, Gemini LP Annex and Gemini Partners, the "Gemini Funds"). Gemini Israel Funds Ltd. is the general partner and/or controlling partner of each of the Gemini Funds. F2: The reporting person, through his position, relationship and/or affiliation with the Gemini Entities, may have shared voting and investment power with respect to the shares beneficially owned by the Gemini Funds. As such, the reporting person may be deemed to have or share beneficial ownership of the shares beneficially owned by the Gemini Funds. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |
| Series A Preferred StockSEC Table II · derivative / convertible security | IndirectSee footnote | 0 |
Reported balance
After 2021-07-27 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-07-27 · Conversion · Disposed 1,667,090 · Balance 0 F3: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F1: The shares are held directly by Gemini Israel IV L.P. ("Gemini LP"), Gemini Israel IV (Annex Fund) L.P. ("Gemini LP Annex"), Gemini Partners Investors IV L.P. ("Gemini Partners") and Gemini Partners Investors IV (Annex Fund) L.P. ("Gemini Partners Annex," and together with Gemini LP, Gemini LP Annex and Gemini Partners, the "Gemini Funds"). Gemini Israel Funds Ltd. is the general partner and/or controlling partner of each of the Gemini Funds. F2: The reporting person, through his position, relationship and/or affiliation with the Gemini Entities, may have shared voting and investment power with respect to the shares beneficially owned by the Gemini Funds. As such, the reporting person may be deemed to have or share beneficial ownership of the shares beneficially owned by the Gemini Funds. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |
| Series B Preferred StockSEC Table II · derivative / convertible security | IndirectSee footnote | 0 |
Reported balance
After 2021-07-27 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-07-27 · Conversion · Disposed 1,531,301 · Balance 0 F3: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F1: The shares are held directly by Gemini Israel IV L.P. ("Gemini LP"), Gemini Israel IV (Annex Fund) L.P. ("Gemini LP Annex"), Gemini Partners Investors IV L.P. ("Gemini Partners") and Gemini Partners Investors IV (Annex Fund) L.P. ("Gemini Partners Annex," and together with Gemini LP, Gemini LP Annex and Gemini Partners, the "Gemini Funds"). Gemini Israel Funds Ltd. is the general partner and/or controlling partner of each of the Gemini Funds. F2: The reporting person, through his position, relationship and/or affiliation with the Gemini Entities, may have shared voting and investment power with respect to the shares beneficially owned by the Gemini Funds. As such, the reporting person may be deemed to have or share beneficial ownership of the shares beneficially owned by the Gemini Funds. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |
| Series C Preferred StockSEC Table II · derivative / convertible security | IndirectSee footnote | 0 |
Reported balance
After 2021-07-27 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-07-27 · Conversion · Disposed 935,247 · Balance 0 F3: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F1: The shares are held directly by Gemini Israel IV L.P. ("Gemini LP"), Gemini Israel IV (Annex Fund) L.P. ("Gemini LP Annex"), Gemini Partners Investors IV L.P. ("Gemini Partners") and Gemini Partners Investors IV (Annex Fund) L.P. ("Gemini Partners Annex," and together with Gemini LP, Gemini LP Annex and Gemini Partners, the "Gemini Funds"). Gemini Israel Funds Ltd. is the general partner and/or controlling partner of each of the Gemini Funds. F2: The reporting person, through his position, relationship and/or affiliation with the Gemini Entities, may have shared voting and investment power with respect to the shares beneficially owned by the Gemini Funds. As such, the reporting person may be deemed to have or share beneficial ownership of the shares beneficially owned by the Gemini Funds. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |
| Series F Preferred StockSEC Table II · derivative / convertible security | IndirectSee footnote | 0 |
Reported balance
After 2021-07-27 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-07-27 · Conversion · Disposed 219,244 · Balance 0 F3: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F4: Includes 30,755 shares issued pursuant to a preset automatic anti-dilution adjustment set forth in the terms of the Series F Preferred Stock. F1: The shares are held directly by Gemini Israel IV L.P. ("Gemini LP"), Gemini Israel IV (Annex Fund) L.P. ("Gemini LP Annex"), Gemini Partners Investors IV L.P. ("Gemini Partners") and Gemini Partners Investors IV (Annex Fund) L.P. ("Gemini Partners Annex," and together with Gemini LP, Gemini LP Annex and Gemini Partners, the "Gemini Funds"). Gemini Israel Funds Ltd. is the general partner and/or controlling partner of each of the Gemini Funds. F2: The reporting person, through his position, relationship and/or affiliation with the Gemini Entities, may have shared voting and investment power with respect to the shares beneficially owned by the Gemini Funds. As such, the reporting person may be deemed to have or share beneficial ownership of the shares beneficially owned by the Gemini Funds. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares are held directly by Gemini Israel IV L.P. ("Gemini LP"), Gemini Israel IV (Annex Fund) L.P. ("Gemini LP Annex"), Gemini Partners Investors IV L.P. ("Gemini Partners") and Gemini Partners Investors IV (Annex Fund) L.P. ("Gemini Partners Annex," and together with Gemini LP, Gemini LP Annex and Gemini Partners, the "Gemini Funds"). Gemini Israel Funds Ltd. is the general partner and/or controlling partner of each of the Gemini Funds.
F2: The reporting person, through his position, relationship and/or affiliation with the Gemini Entities, may have shared voting and investment power with respect to the shares beneficially owned by the Gemini Funds. As such, the reporting person may be deemed to have or share beneficial ownership of the shares beneficially owned by the Gemini Funds. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F3: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering.
F4: Includes 30,755 shares issued pursuant to a preset automatic anti-dilution adjustment set forth in the terms of the Series F Preferred Stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 29, 2022 Filed Dec 1, 2022 21:16 UTC | JFrog Ltd FROG · Entity 1682 | SaleOrdinary Shares | 25,000 | $21.17 | $529,350.00 |
DisclosureSEC source: 0001209191-22-059184 · doc4.xml · nonDerivative · entry 2 Sela Yossi · CIK 0001402094 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 8,564,700 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.96 to $21.375, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: The reported securities are shares held of record by Gemini V. Gemini Capital Associates V LP (Gemini Associates LP) is the general partner of Gemini V and Gemini Capital Associates V GP, Ltd. (Gemini Associates GP) is the general partner of Gemini Associates LP. The reporting person is a managing partner of Gemini Associates GP and disclaims beneficial ownership of the shares held of record Gemini V except to the extent of his pecuniary interest therein. Read SEC document |
| November 29, 2022 Filed Dec 1, 2022 21:16 UTC | JFrog Ltd FROG · Entity 1682 | OtherOrdinary Shares | 844,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-059184 · doc4.xml · nonDerivative · entry 1 Sela Yossi · CIK 0001402094 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 8,589,700 F1 · kind: Represents an in-kind distribution by Gemini Israel V Limited Partnership (Gemini V) without consideration to its partners. F2 · ownership.nature: The reported securities are shares held of record by Gemini V. Gemini Capital Associates V LP (Gemini Associates LP) is the general partner of Gemini V and Gemini Capital Associates V GP, Ltd. (Gemini Associates GP) is the general partner of Gemini Associates LP. The reporting person is a managing partner of Gemini Associates GP and disclaims beneficial ownership of the shares held of record Gemini V except to the extent of his pecuniary interest therein. Read SEC document |
| May 17, 2022 Filed May 19, 2022 15:37 UTC | JFrog Ltd FROG · Entity 1682 | GrantOrdinary Shares | 9,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030345 · doc4.xml · nonDerivative · entry 1 Sela Yossi · CIK 0001402094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,349 F1 · shares: The ordinary shares are represented by restricted stock units which vest in four equal quarterly installments beginning on August 17, 2022. Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 21:01 UTC | Teads Holding Co. OB · Entity 7241 | ConversionSeries F Preferred Stock · Derivative | 219,244 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-097647 · tm2123665-5_4seq1.xml · derivative · entry 5 Sela Yossi · CIK 0001402094 · Director · Former 10% Owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 249,999 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F3 · derivative.exercise_price: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F3 · derivative.exercise_date: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F3 · derivative.expiration_date: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F4 · derivative.underlying_shares: Includes 30,755 shares issued pursuant to a preset automatic anti-dilution adjustment set forth in the terms of the Series F Preferred Stock. F1 · ownership.nature: The shares are held directly by Gemini Israel IV L.P. ("Gemini LP"), Gemini Israel IV (Annex Fund) L.P. ("Gemini LP Annex"), Gemini Partners Investors IV L.P. ("Gemini Partners") and Gemini Partners Investors IV (Annex Fund) L.P. ("Gemini Partners Annex," and together with Gemini LP, Gemini LP Annex and Gemini Partners, the "Gemini Funds"). Gemini Israel Funds Ltd. is the general partner and/or controlling partner of each of the Gemini Funds. F2 · ownership.nature: The reporting person, through his position, relationship and/or affiliation with the Gemini Entities, may have shared voting and investment power with respect to the shares beneficially owned by the Gemini Funds. As such, the reporting person may be deemed to have or share beneficial ownership of the shares beneficially owned by the Gemini Funds. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 21:01 UTC | Teads Holding Co. OB · Entity 7241 | ConversionSeries C Preferred Stock · Derivative | 935,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-097647 · tm2123665-5_4seq1.xml · derivative · entry 4 Sela Yossi · CIK 0001402094 · Director · Former 10% Owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 935,247 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F3 · derivative.exercise_price: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F3 · derivative.exercise_date: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F3 · derivative.expiration_date: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F1 · ownership.nature: The shares are held directly by Gemini Israel IV L.P. ("Gemini LP"), Gemini Israel IV (Annex Fund) L.P. ("Gemini LP Annex"), Gemini Partners Investors IV L.P. ("Gemini Partners") and Gemini Partners Investors IV (Annex Fund) L.P. ("Gemini Partners Annex," and together with Gemini LP, Gemini LP Annex and Gemini Partners, the "Gemini Funds"). Gemini Israel Funds Ltd. is the general partner and/or controlling partner of each of the Gemini Funds. F2 · ownership.nature: The reporting person, through his position, relationship and/or affiliation with the Gemini Entities, may have shared voting and investment power with respect to the shares beneficially owned by the Gemini Funds. As such, the reporting person may be deemed to have or share beneficial ownership of the shares beneficially owned by the Gemini Funds. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 21:01 UTC | Teads Holding Co. OB · Entity 7241 | ConversionSeries B Preferred Stock · Derivative | 1,531,301 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-097647 · tm2123665-5_4seq1.xml · derivative · entry 3 Sela Yossi · CIK 0001402094 · Director · Former 10% Owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 1,531,301 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F3 · derivative.exercise_price: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F3 · derivative.exercise_date: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F3 · derivative.expiration_date: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F1 · ownership.nature: The shares are held directly by Gemini Israel IV L.P. ("Gemini LP"), Gemini Israel IV (Annex Fund) L.P. ("Gemini LP Annex"), Gemini Partners Investors IV L.P. ("Gemini Partners") and Gemini Partners Investors IV (Annex Fund) L.P. ("Gemini Partners Annex," and together with Gemini LP, Gemini LP Annex and Gemini Partners, the "Gemini Funds"). Gemini Israel Funds Ltd. is the general partner and/or controlling partner of each of the Gemini Funds. F2 · ownership.nature: The reporting person, through his position, relationship and/or affiliation with the Gemini Entities, may have shared voting and investment power with respect to the shares beneficially owned by the Gemini Funds. As such, the reporting person may be deemed to have or share beneficial ownership of the shares beneficially owned by the Gemini Funds. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 21:01 UTC | Teads Holding Co. OB · Entity 7241 | ConversionSeries A Preferred Stock · Derivative | 1,667,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-097647 · tm2123665-5_4seq1.xml · derivative · entry 2 Sela Yossi · CIK 0001402094 · Director · Former 10% Owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 1,667,090 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F3 · derivative.exercise_price: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F3 · derivative.exercise_date: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F3 · derivative.expiration_date: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F1 · ownership.nature: The shares are held directly by Gemini Israel IV L.P. ("Gemini LP"), Gemini Israel IV (Annex Fund) L.P. ("Gemini LP Annex"), Gemini Partners Investors IV L.P. ("Gemini Partners") and Gemini Partners Investors IV (Annex Fund) L.P. ("Gemini Partners Annex," and together with Gemini LP, Gemini LP Annex and Gemini Partners, the "Gemini Funds"). Gemini Israel Funds Ltd. is the general partner and/or controlling partner of each of the Gemini Funds. F2 · ownership.nature: The reporting person, through his position, relationship and/or affiliation with the Gemini Entities, may have shared voting and investment power with respect to the shares beneficially owned by the Gemini Funds. As such, the reporting person may be deemed to have or share beneficial ownership of the shares beneficially owned by the Gemini Funds. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 21:01 UTC | Teads Holding Co. OB · Entity 7241 | ConversionCommon Stock | 4,383,637 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-097647 · tm2123665-5_4seq1.xml · nonDerivative · entry 1 Sela Yossi · CIK 0001402094 · Director · Former 10% Owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,921,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F3 · balance_after: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F1 · ownership.nature: The shares are held directly by Gemini Israel IV L.P. ("Gemini LP"), Gemini Israel IV (Annex Fund) L.P. ("Gemini LP Annex"), Gemini Partners Investors IV L.P. ("Gemini Partners") and Gemini Partners Investors IV (Annex Fund) L.P. ("Gemini Partners Annex," and together with Gemini LP, Gemini LP Annex and Gemini Partners, the "Gemini Funds"). Gemini Israel Funds Ltd. is the general partner and/or controlling partner of each of the Gemini Funds. F2 · ownership.nature: The reporting person, through his position, relationship and/or affiliation with the Gemini Entities, may have shared voting and investment power with respect to the shares beneficially owned by the Gemini Funds. As such, the reporting person may be deemed to have or share beneficial ownership of the shares beneficially owned by the Gemini Funds. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| May 14, 2021 Filed May 18, 2021 22:04 UTC | JFrog Ltd FROG · Entity 1682 | GrantOrdinary Shares | 4,797 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033684 · doc4.xml · nonDerivative · entry 1 Sela Yossi · CIK 0001402094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,797 F1 · shares: The ordinary shares are represented by restricted stock units which vest in four equal quarterly installments beginning on August 14, 2021. Read SEC document |
| February 19, 2021 Filed Feb 20, 2021 00:31 UTC | JFrog Ltd FROG · Entity 1682 | SaleOrdinary Shares | 7,692 | $68.20 | $524,599.02 |
DisclosureSEC source: 0001104659-21-025877 · a4.xml · nonDerivative · entry 11 Sela Yossi · CIK 0001402094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 95,295 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.00 to $68.50, inclusive. F8 · ownership.nature: The reported securities are shares held of record by Gemini Partners Investors V L.P. (Gemini Partners). Gemini Israel Funds IV Ltd. (Gemini Israel) is the general partner of Gemini Partners. The reporting person is a managing partner of Gemini Israel and disclaims beneficial ownership of the shares held of record Gemini Partners except to the extent of his pecuniary interest therein. Read SEC document |
| February 19, 2021 Filed Feb 20, 2021 00:31 UTC | JFrog Ltd FROG · Entity 1682 | SaleOrdinary Shares | 68,991 | $68.20 | $4,705,227.59 |
DisclosureSEC source: 0001104659-21-025877 · a4.xml · nonDerivative · entry 6 Sela Yossi · CIK 0001402094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 9,434,200 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.00 to $68.50, inclusive. F2 · ownership.nature: The reported securities are shares held of record by shares held of record by Gemini V. Gemini Capital Associates V LP (Gemini Associates LP) is the general partner of Gemini V and Gemini Capital Associates V GP, Ltd. (Gemini Associates GP) is the general partner of Gemini Associates LP. The reporting person is a managing partner of Gemini Associates GP and disclaims beneficial ownership of the shares held of record Gemini Partners except to the extent of his pecuniary interest therein. Read SEC document |
| February 18, 2021 Filed Feb 20, 2021 00:31 UTC | JFrog Ltd FROG · Entity 1682 | SaleOrdinary Shares | 148 | $66.62 | $9,860.04 |
DisclosureSEC source: 0001104659-21-025877 · a4.xml · nonDerivative · entry 10 Sela Yossi · CIK 0001402094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 102,987 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.64 to $66.78, inclusive. F8 · ownership.nature: The reported securities are shares held of record by Gemini Partners Investors V L.P. (Gemini Partners). Gemini Israel Funds IV Ltd. (Gemini Israel) is the general partner of Gemini Partners. The reporting person is a managing partner of Gemini Israel and disclaims beneficial ownership of the shares held of record Gemini Partners except to the extent of his pecuniary interest therein. Read SEC document |
| February 18, 2021 Filed Feb 20, 2021 00:31 UTC | JFrog Ltd FROG · Entity 1682 | SaleOrdinary Shares | 6,557 | $65.93 | $432,329.89 |
DisclosureSEC source: 0001104659-21-025877 · a4.xml · nonDerivative · entry 9 Sela Yossi · CIK 0001402094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 103,135 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.63 to $66.53, inclusive. F8 · ownership.nature: The reported securities are shares held of record by Gemini Partners Investors V L.P. (Gemini Partners). Gemini Israel Funds IV Ltd. (Gemini Israel) is the general partner of Gemini Partners. The reporting person is a managing partner of Gemini Israel and disclaims beneficial ownership of the shares held of record Gemini Partners except to the extent of his pecuniary interest therein. Read SEC document |
| February 18, 2021 Filed Feb 20, 2021 00:31 UTC | JFrog Ltd FROG · Entity 1682 | SaleOrdinary Shares | 1,319 | $65.08 | $85,841.18 |
DisclosureSEC source: 0001104659-21-025877 · a4.xml · nonDerivative · entry 8 Sela Yossi · CIK 0001402094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 109,692 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.63 to $65.62, inclusive. F8 · ownership.nature: The reported securities are shares held of record by Gemini Partners Investors V L.P. (Gemini Partners). Gemini Israel Funds IV Ltd. (Gemini Israel) is the general partner of Gemini Partners. The reporting person is a managing partner of Gemini Israel and disclaims beneficial ownership of the shares held of record Gemini Partners except to the extent of his pecuniary interest therein. Read SEC document |
| February 18, 2021 Filed Feb 20, 2021 00:31 UTC | JFrog Ltd FROG · Entity 1682 | SaleOrdinary Shares | 532 | $66.74 | $35,506.27 |
DisclosureSEC source: 0001104659-21-025877 · a4.xml · nonDerivative · entry 5 Sela Yossi · CIK 0001402094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 9,503,191 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.64 to $66.78, inclusive. F2 · ownership.nature: The reported securities are shares held of record by shares held of record by Gemini V. Gemini Capital Associates V LP (Gemini Associates LP) is the general partner of Gemini V and Gemini Capital Associates V GP, Ltd. (Gemini Associates GP) is the general partner of Gemini Associates LP. The reporting person is a managing partner of Gemini Associates GP and disclaims beneficial ownership of the shares held of record Gemini Partners except to the extent of his pecuniary interest therein. Read SEC document |
| February 18, 2021 Filed Feb 20, 2021 00:31 UTC | JFrog Ltd FROG · Entity 1682 | SaleOrdinary Shares | 53,128 | $66.00 | $3,506,224.86 |
DisclosureSEC source: 0001104659-21-025877 · a4.xml · nonDerivative · entry 4 Sela Yossi · CIK 0001402094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 9,503,723 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.63 to $66.53, inclusive. F2 · ownership.nature: The reported securities are shares held of record by shares held of record by Gemini V. Gemini Capital Associates V LP (Gemini Associates LP) is the general partner of Gemini V and Gemini Capital Associates V GP, Ltd. (Gemini Associates GP) is the general partner of Gemini Associates LP. The reporting person is a managing partner of Gemini Associates GP and disclaims beneficial ownership of the shares held of record Gemini Partners except to the extent of his pecuniary interest therein. Read SEC document |
| February 18, 2021 Filed Feb 20, 2021 00:31 UTC | JFrog Ltd FROG · Entity 1682 | SaleOrdinary Shares | 18,316 | $65.23 | $1,194,666.59 |
DisclosureSEC source: 0001104659-21-025877 · a4.xml · nonDerivative · entry 3 Sela Yossi · CIK 0001402094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 9,556,851 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.63 to $65.62, inclusive. F2 · ownership.nature: The reported securities are shares held of record by shares held of record by Gemini V. Gemini Capital Associates V LP (Gemini Associates LP) is the general partner of Gemini V and Gemini Capital Associates V GP, Ltd. (Gemini Associates GP) is the general partner of Gemini Associates LP. The reporting person is a managing partner of Gemini Associates GP and disclaims beneficial ownership of the shares held of record Gemini Partners except to the extent of his pecuniary interest therein. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 00:31 UTC | JFrog Ltd FROG · Entity 1682 | SaleOrdinary Shares | 16,049 | $65.77 | $1,055,581.25 |
DisclosureSEC source: 0001104659-21-025877 · a4.xml · nonDerivative · entry 7 Sela Yossi · CIK 0001402094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 111,011 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.38 to $66.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (7) to this Form 4. F8 · ownership.nature: The reported securities are shares held of record by Gemini Partners Investors V L.P. (Gemini Partners). Gemini Israel Funds IV Ltd. (Gemini Israel) is the general partner of Gemini Partners. The reporting person is a managing partner of Gemini Israel and disclaims beneficial ownership of the shares held of record Gemini Partners except to the extent of his pecuniary interest therein. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 00:31 UTC | JFrog Ltd FROG · Entity 1682 | SaleOrdinary Shares | 143,951 | $65.77 | $9,467,988.36 |
DisclosureSEC source: 0001104659-21-025877 · a4.xml · nonDerivative · entry 2 Sela Yossi · CIK 0001402094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 9,575,167 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.38 to $66.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (7) to this Form 4. F2 · ownership.nature: The reported securities are shares held of record by shares held of record by Gemini V. Gemini Capital Associates V LP (Gemini Associates LP) is the general partner of Gemini V and Gemini Capital Associates V GP, Ltd. (Gemini Associates GP) is the general partner of Gemini Associates LP. The reporting person is a managing partner of Gemini Associates GP and disclaims beneficial ownership of the shares held of record Gemini Partners except to the extent of his pecuniary interest therein. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 00:31 UTC | JFrog Ltd FROG · Entity 1682 | OtherOrdinary Shares | 2,859,815 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-025877 · a4.xml · nonDerivative · entry 1 Sela Yossi · CIK 0001402094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 9,719,118 F1 · kind: Represents an in-kind distribution by Gemini Israel V Limited Partnership (Gemini V) without consideration to its partners. F1 · price: Represents an in-kind distribution by Gemini Israel V Limited Partnership (Gemini V) without consideration to its partners. F2 · ownership.nature: The reported securities are shares held of record by shares held of record by Gemini V. Gemini Capital Associates V LP (Gemini Associates LP) is the general partner of Gemini V and Gemini Capital Associates V GP, Ltd. (Gemini Associates GP) is the general partner of Gemini Associates LP. The reporting person is a managing partner of Gemini Associates GP and disclaims beneficial ownership of the shares held of record Gemini Partners except to the extent of his pecuniary interest therein. Read SEC document |
| September 18, 2020 Filed Sep 22, 2020 00:01 UTC | JFrog Ltd FROG · Entity 1682 | ConversionSeries B Convertible Preferred Shares · Derivative | 18,697 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-025838 · doc4.xml · derivative · entry 6 Sela Yossi · CIK 0001402094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Ordinary Shares · 18,697 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Series B Convertible Preferred Shares automatically converted into Ordinary Shares on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date. F2 · derivative.exercise_date: The Series B Convertible Preferred Shares automatically converted into Ordinary Shares on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date. F2 · derivative.expiration_date: The Series B Convertible Preferred Shares automatically converted into Ordinary Shares on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date. F4 · ownership.nature: The reported securities are shares held of record by Gemini Partners Investors V L.P. (Gemini Partners). Gemini Israel Funds IV Ltd. (Gemini Israel) is the general partner of Gemini Partners. The reporting person is a managing partner of Gemini Israel and disclaims beneficial ownership of the shares held of record Gemini Partners except to the extent of his pecuniary interest therein. Read SEC document |
| September 18, 2020 Filed Sep 22, 2020 00:01 UTC | JFrog Ltd FROG · Entity 1682 | ConversionSeries B Convertible Preferred Shares · Derivative | 1,850,988 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-025838 · doc4.xml · derivative · entry 5 Sela Yossi · CIK 0001402094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Ordinary Shares · 1,850,988 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Series B Convertible Preferred Shares automatically converted into Ordinary Shares on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date. F2 · derivative.exercise_date: The Series B Convertible Preferred Shares automatically converted into Ordinary Shares on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date. F2 · derivative.expiration_date: The Series B Convertible Preferred Shares automatically converted into Ordinary Shares on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date. F3 · ownership.nature: The reported securities are shares held of record by shares held of record by Gemini Israel V Limited Partnership (Gemini V). Gemini Capital Associates V LP (Gemini Associates LP) is the general partner of Gemini V and Gemini Capital Associates V GP, Ltd. (Gemini Associates GP) is the general partner of Gemini Associates LP. The reporting person is a managing partner of Gemini Associates GP and disclaims beneficial ownership of the shares held of record Gemini Partners except to the extent of his pecuniary interest therein. Read SEC document |
| September 18, 2020 Filed Sep 22, 2020 00:01 UTC | JFrog Ltd FROG · Entity 1682 | ConversionSeries A-1 Convertible Preferred Shares · Derivative | 108,363 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-025838 · doc4.xml · derivative · entry 4 Sela Yossi · CIK 0001402094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Ordinary Shares · 108,363 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series A-1 Convertible Preferred Shares automatically converted into Ordinary Shares on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date. F1 · derivative.exercise_date: The Series A-1 Convertible Preferred Shares automatically converted into Ordinary Shares on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date. F1 · derivative.expiration_date: The Series A-1 Convertible Preferred Shares automatically converted into Ordinary Shares on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date. F4 · ownership.nature: The reported securities are shares held of record by Gemini Partners Investors V L.P. (Gemini Partners). Gemini Israel Funds IV Ltd. (Gemini Israel) is the general partner of Gemini Partners. The reporting person is a managing partner of Gemini Israel and disclaims beneficial ownership of the shares held of record Gemini Partners except to the extent of his pecuniary interest therein. Read SEC document |
| September 18, 2020 Filed Sep 22, 2020 00:01 UTC | JFrog Ltd FROG · Entity 1682 | ConversionSeries A-1 Convertible Preferred Shares · Derivative | 10,727,945 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-025838 · doc4.xml · derivative · entry 3 Sela Yossi · CIK 0001402094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Ordinary Shares · 10,727,945 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series A-1 Convertible Preferred Shares automatically converted into Ordinary Shares on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date. F1 · derivative.exercise_date: The Series A-1 Convertible Preferred Shares automatically converted into Ordinary Shares on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date. F1 · derivative.expiration_date: The Series A-1 Convertible Preferred Shares automatically converted into Ordinary Shares on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date. F3 · ownership.nature: The reported securities are shares held of record by shares held of record by Gemini Israel V Limited Partnership (Gemini V). Gemini Capital Associates V LP (Gemini Associates LP) is the general partner of Gemini V and Gemini Capital Associates V GP, Ltd. (Gemini Associates GP) is the general partner of Gemini Associates LP. The reporting person is a managing partner of Gemini Associates GP and disclaims beneficial ownership of the shares held of record Gemini Partners except to the extent of his pecuniary interest therein. Read SEC document |
| September 18, 2020 Filed Sep 22, 2020 00:01 UTC | JFrog Ltd FROG · Entity 1682 | ConversionOrdinary Shares | 127,060 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-025838 · doc4.xml · nonDerivative · entry 2 Sela Yossi · CIK 0001402094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 127,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series A-1 Convertible Preferred Shares automatically converted into Ordinary Shares on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date. F2 · price: The Series B Convertible Preferred Shares automatically converted into Ordinary Shares on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date. F4 · ownership.nature: The reported securities are shares held of record by Gemini Partners Investors V L.P. (Gemini Partners). Gemini Israel Funds IV Ltd. (Gemini Israel) is the general partner of Gemini Partners. The reporting person is a managing partner of Gemini Israel and disclaims beneficial ownership of the shares held of record Gemini Partners except to the extent of his pecuniary interest therein. Read SEC document |
| September 18, 2020 Filed Sep 22, 2020 00:01 UTC | JFrog Ltd FROG · Entity 1682 | ConversionOrdinary Shares | 12,578,933 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-025838 · doc4.xml · nonDerivative · entry 1 Sela Yossi · CIK 0001402094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 12,578,933 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series A-1 Convertible Preferred Shares automatically converted into Ordinary Shares on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date. F2 · price: The Series B Convertible Preferred Shares automatically converted into Ordinary Shares on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date. F3 · ownership.nature: The reported securities are shares held of record by shares held of record by Gemini Israel V Limited Partnership (Gemini V). Gemini Capital Associates V LP (Gemini Associates LP) is the general partner of Gemini V and Gemini Capital Associates V GP, Ltd. (Gemini Associates GP) is the general partner of Gemini Associates LP. The reporting person is a managing partner of Gemini Associates GP and disclaims beneficial ownership of the shares held of record Gemini Partners except to the extent of his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.